×
About 2,683 results

ALLMedicine™ Edema Center

Research & Reviews  937 results

Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgic...
https://doi.org/10.1177/11206721211046718
European Journal of Ophthalmology; Miguel-Escuder L, Olate-Pérez Á et. al.

Nov 28th, 2021 - Cystoid macular edema (CME) is the most common cause of decreased visual acuity after both vitrectomy and cataract surgery. Various strategies have been used for its treatment, such as intravitreal corticosteroids. The intravitreal fluocinolone ac...

Radiation Maculopathy is Anticipated by OCT Hyperreflective Retinal Foci: a Large, Pros...
https://doi.org/10.1097/IAE.0000000000003359
Retina (Philadelphia, Pa.); Parrozzani R, Midena G et. al.

Nov 23rd, 2021 - To investigate, by means of spectral domain optical coherence tomography (SD-OCT), retinal reflectivity changes as an early biomarker anticipating radiation induced macular edema (ME) in patients treated by Iodine-125 (I-125) brachytherapy. Thirty...

Treatment patterns and persistence rates with anti-VEGF treatment for diabetic macular ...
https://doi.org/10.1111/dme.14746
Diabetic Medicine : a Journal of the British Diabetic Ass... Peto T, Akerele T et. al.

Nov 20th, 2021 - Anti-vascular endothelial growth factors (anti-VEGFs) are considered standard of care therapy for diabetic macular edema (DME). This study examined treatment patterns and outcomes in patients with DME treated with anti-VEGF therapy. Using anonymiz...

Bone Marrow Edema: Overview of Etiology and Treatment Strategies.
https://doi.org/10.2106/JBJS.21.00300
The Journal of Bone and Joint Surgery. American Volume; Tarantino U, Greggi C et. al.

Nov 16th, 2021 - Bone marrow edema (BME) is a nonspecific but relevant finding, usually indicating the presence of an underlying pathology. The gold standard technique for detecting BME is magnetic resonance imaging (MRI), as it allows for a correct diagnosis to b...

see more →

Guidelines  1 results

Rationale for the diabetic retinopathy clinical research network treatment protocol for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253487
Ophthalmology , et. al.

Dec 6th, 2011 - To describe the underlying principles used to develop a web-based algorithm that incorporated intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema (DME) in a Diabetic Retinopathy Clinical Research N...

see more →

Drugs  11 results see all →

News  124 results

Case Reports Underscore Risk for Cerebral Edema, AFCE in Children With COVID-19
https://www.medscape.com/viewarticle/960526

Oct 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An 8-year-old girl who was infected with SARS-CoV-2 died after developing an extremely rare condition known as acute fulminant cerebral edema (AFC...

Diabetic Macular Edema: Mixed Results for Brolucizumab
https://www.medscape.com/viewarticle/958719

Sep 14th, 2021 - Brolucizumab (Beovu) can improve visual acuity of patients with diabetic macular edema (DME) using fewer injections than needed for aflibercept (Eylea), but this advantage may come at the cost of vision-threatening intraocular inflammation for som...

Faricimab Could Save Injections for Age-Related Macular Degeneration and Diabetic Macular Edema
https://www.medscape.com/viewarticle/950466

May 4th, 2021 - Faricimab, an experimental drug, could reduce the number of injections needed to treat both age-related macular degeneration (AMD) and diabetic macular edema (DME), phase 3 trials suggest. Faricimab's mechanism of action appears to make it longer-...

Positive Topline Data for Lilly's Donanemab in Early Alzheimer's
https://www.medscape.com/viewarticle/943905

Jan 11th, 2021 - Donanemab (Eli Lilly), an investigational antiamyloid therapy, significantly slowed decline in a composite measure of cognition and daily function in patients with early symptomatic Alzheimer's disease (AD) in the phase 2 TRAILBLAZER-ALZ study, th...

Dexamethasone May Curb Efficacy of Immune Checkpoint Blockade in Glioblastoma
https://www.medscape.com/viewarticle/941951

Dec 4th, 2020 - NEW YORK (Reuters Health) - Dexamethasone given to combat cerebral edema in patients with glioblastoma may negatively affect immunotherapy, according to work in mice and clinical data. "There are many biologic, endogenous factors contributing to i...

see more →